28 July 2016

Sheeran shines on Romanian trials

James Crux

Brian Sheeran, chairman of green technology company Virotec, delivered some good news to investors today with exciting news of trials in Romania of its Bauxsol waste water cleaning technology.

Sheeran and Dr David McConchie, a fellow director and the group's chief scientific consultant, had just visited Baia Mare in Romania, joining other Virotec staff who were treating 3 million litres of Acid Mine Drainage (AMD) with the group's Bauxsol technology. 'We've had large enquiry levels from Europe', said Sheeran, 'and were invited to Baia Mare by Romanian mining company Remin to do trials'.

Formerly a mining venture Down Under, Virotec (VTI) has worldwide marketing and distribution rights to 'Bauxsol', a 'green' technology that neutralises acid and removes heavy metals from environmentally contaminated water. Although the actual results have not been released yet, McConchie hinted at positive news. 'The initial trials gave fantastic results', he added. 'Our aim at Virotec is not only to protect the environment but to do it in an economically appealing way that will save mining companies money'.

All of this should have impressed observers from the United Nations Environment Programme, the European Union in Brussels and the London Stock Exchange who attended the Romanian trials. Significantly, the pair also boasted that the United States EPA is also currently trialling the technology. 'Trials in the US should be completed by December and we're hopeful of gaining EPA approval for the product for America', said Sheeran.

Virotec, already quoted on the Australian Stock Exchange, listed on Aim in July following a placing of 27.5 million new shares at 14p raising £3.36 million net. 'We came to Aim to internationalise the technology and be first to market', explained Sheeran. W H Ireland was broker to the float.

Today the shares were unchanged at 12.25p.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Staffline undaunted by Brexit

Recruitment is a sector that’s been underperforming all year and it got a further kicking after the Brexit vote. This means there’s plenty of upside if the economic background turns out to be OK or if companies’ business models prove to be resilient. Staffline shares could be well placed to benefit.

Synectics on the road to recovery

Synectics (AIM: SNX), the surveillance systems specialist, is on the road to recovery. The shares were hit badly by the downturn in the oil and gas industry which historically has been a key customer. Happily the slack is now being taken up elsewhere, with the order book up 34 per cent from the start of the year.

Profit from playing by the rules

One ‘industry’ that has boomed over recent decades is compliance. Everything has become a lot stricter as far as rules and regulations are concerned. It’s not enough to abide by the processes of our workplaces, we also need to demonstrate that proper procedures are in place and are being complied with. That’s good news for Ideagen (AIM: IDEA) whose software helps over 2,000 companies in regulated industries manage their governance, risk and compliance.

Collagen targets a step up in scale

Collagen Solutions (AIM: COS) results gave new CEO Jamal Rushdy an opportunity to set out his strategy for the company. Collagen has an unusually broad geographic footprint for a company of its £13 million size. The plan is to use this platform to exploit Collagen’s expertise in tissue engineering, both through contract manufacturing and developing its own medical devices.

Concepta Diagnostics reverses into Frontier shell

Cash shell Frontier Resources (AIM: FRI) has announced the reverse takeover of Concepta Diagnostics. Concepta is focused on women’s fertility and plans to have its first product in the market shortly.

Beam me up

Satellite Solutions Worldwide (AIM: SAT) has just pulled off a significant acquisition which increases its user base by 40 per cent. Avonline is a major UK competitor in satellite broadband and is being acquired for £10 million, funded by a further financing agreement with the Business Growth Fund.

More News